Showing 13,181 - 13,200 results of 48,036 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (mean decrease)) ))', query time: 1.43s Refine Results
  1. 13181

    Cell-cell adhesion and expression profile of osteoblastic markers of 5-HT<sub>2B</sub>R-/- osteoblasts. by Yasmine Chabbi-Achengli (459899)

    Published 2013
    “…Runx2, osteocalcin expression levels were not modified by the absence of 5-HT<sub>2B</sub>R, whereas cyclin D1, alkaline phosphatase and osteopontin expression levels were decreased. …”
  2. 13182
  3. 13183

    HC11 cells increase Pthlh gene expression and activity via cAMP with increases in intracellular 5HT. by Celeste M. Sheftel (9557588)

    Published 2020
    “…</b> cAMP concentration at 48 hours increased in non-lactogenic control cells and 5HTP treated cells, whereas FLX treated cells decreased cAMP concentration compared to lactogenic control. …”
  4. 13184

    Effects of knockdown (KD) on enhancer activity of the BAC-5.4kb genome sequence encompassing <i>Start</i>. by Kai Otsuka (10507952)

    Published 2022
    “…(C) KD of <i>Start</i> decreased enhancer activity of TK-BAC-5.4kb. (Left) KD efficiency of two shRNAs (shRNA-v1 and shRNA-v2) was evaluated by qRT-PCR. …”
  5. 13185
  6. 13186
  7. 13187

    IC<sub>50</sub> values for inhibition of RdRp activity of NS5B by Nuc (3′-d′CTP) and NNIs. by Sarah E. Boyce (434826)

    Published 2014
    “…<p>Numbers represent mean and standard deviation of IC<sub>50</sub> values determined for each inhibitor against the set of NS5B constructs. …”
  8. 13188

    Presentation 1_Loss-of-function mitochondrial DNA polymerase gamma variants cause vascular smooth muscle cells to secrete a diffusible mitogenic factor.pdf by Samantha Rothwell (20733932)

    Published 2025
    “…Live-cell imaging growth analyses again showed increased growth in A7r5 cells transfected with p.Tyr955Cys but a decreased growth with p.Arg1138Cys, while p.Tyr955Cys increased growth of HeLa cells. …”
  9. 13189

    SMA and SM22 expression was attenuated in homogenates of palladin E11.5 knockdown embryos, in isolated umbilical vessels and in dorsal aortae. by Li Jin (40265)

    Published 2010
    “…The signals were normalized to GAPDH. Values represent the mean±SEM (n = 3). *, p<0.05. D) The expression of SMA, SM22, and SM MHC mRNA is markedly decreased in umbilical vessels isolated from E11.5 palladin +/− and −/− mice compared to Wt. …”
  10. 13190
  11. 13191
  12. 13192
  13. 13193

    Increase of <i>Shigella</i> infection induced by miR-29b-2-5p is dependent on multiple targets. by Ushasree Sunkavalli (3916721)

    Published 2017
    “…Transcriptomic analysis revealed fifty-two genes down-regulated by miR-29b-2-5p overexpression (≥1.5-fold) and up-regulated upon <i>Shigella</i> infection (≥2-fold, <i>Shigella</i> + cell population; 6 hpi). …”
  14. 13194
  15. 13195
  16. 13196
  17. 13197

    Table_1_Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis.docx by Dora Nemeth (13945512)

    Published 2022
    “…</p>Methods<p>Serological response was measured by quantifying anti-SARS-CoV-2 specific antibodies, while the cell-mediated response was measured by a whole-blood test quantifying the interferon (IFN)-γ response to different SARS-CoV-2-specific domains.…”
  18. 13198

    DataSheet_1_Effects of Acipenserid herpesvirus 2 on the outcome of a Streptococcus iniae co-infection in white sturgeon (Acipenser transmontanus).docx by Eva Marie Quijano Cardé (6944261)

    Published 2024
    “…While a decrease in humoral immunity caused by VZV has been hypothesized as a potentially important factor in IGASI cases, no natural animal model exists to study this process. …”
  19. 13199

    Molecular Modeling-<sub>B</sub>ased Delivery System Enhances Everolimus-Induced Apoptosis in Caco‑2 Cells by Marwan Abdelmahmoud Abdelkarim Maki (6725999)

    Published 2019
    “…However, the meaningful efficacy of EV as a single agent for the treatment of colorectal cancer (CRC) has failed to be proven in multiple clinical trials. …”
  20. 13200